XORTX Therapeutics Inc (XRTX)

NASDAQ: XRTX · Delayed Price · USD
1.35
0.05 (3.85%)
At close: May 27, 2022 3:59 PM
1.40
0.05 (3.70%)
After-hours:May 27, 2022 5:28 PM EDT

Cash Flow Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202120202019
Net Income
-1.65-1.28-0.63
Depreciation & Amortization
0.020.020.02
Share-Based Compensation
0.50.290.03
Other Operating Activities
-4.930.240.33
Operating Cash Flow
-6.06-0.73-0.25
Other Investing Activities
-0.04-0.01-0.01
Investing Cash Flow
-0.04-0.01-0.01
Share Issuance / Repurchase
22.880.90
Other Financing Activities
1.57-0.040.06
Financing Cash Flow
24.460.860.06
Net Cash Flow
18.680.11-0.2
Free Cash Flow
-6.06-0.73-0.25
Free Cash Flow Per Share
-0.62-0.11-0.05
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).